Crinetics Pharmaceuticals, Inc. (CRNX)

37.23 +0.66 (+1.80%) USD  |  NASDAQ  |  Apr 02, 16:00
37.24 +0.01 (+0.03%) After-Hours: 20:00
More

Crinetics Pharmaceuticals EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for CRNX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Plus Therapeutics, Inc. Upgrade
Nektar Therapeutics Upgrade
Madrigal Pharmaceuticals, Inc. Upgrade
Axsome Therapeutics, Inc. Upgrade
Gossamer Bio, Inc. Upgrade